

Unraveling dementia's unequal hold on women — and the science pointing toward a way out.
At Hometown Health DPC, our whole-person approach means we look at the full picture of your health — including the factors that put certain patients at greater risk long before symptoms appear. For women, dementia is one of the most important conversations we’re not having often enough.
The global prevalence of dementia in women aged 65 and older is 80 per 1,000 — compared to 55 per 1,000 in men. A large international meta-analysis confirmed women carry a 12% higher overall dementia risk. And yet, for decades, that disparity was written off as a longevity gap. We now know the reality is far more layered — and far more actionable.
One of the clearest biological drivers of the sex gap is the APOE ε4 gene variant — the strongest known genetic risk factor for late-onset Alzheimer’s. But it doesn’t affect men and women equally. Women with just one copy of APOE ε4 carry a risk roughly equivalent to men who carry two copies. This is most pronounced between ages 60 and 75, and holds consistently across racial and ethnic groups.
Researchers believe estrogen loss during menopause may amplify this gene’s harmful effects — specifically by increasing vulnerability to tau protein accumulation, the kind of neuronal damage APOE ε4 already accelerates. Same gene. Greater hormonal context. Harder hit.
“Women’s longer life expectancy alone does not account for the disparity; physiologic, lifestyle, and genetic factors also are associated.”
— Dr. Deborah Bartz et al., Brigham and Women’s Hospital · JAMA Internal MedicineA landmark 2026 review in the Journal of Clinical Investigation calls for a paradigm shift: the menopausal transition should be treated as a distinct, potentially modifiable neurological risk factor — not just a reproductive milestone. This is exactly the kind of evidence-informed, proactive thinking that shapes how we approach women’s care at Hometown Health.
The 2024 Lancet Commission identified 14 modifiable risk factors that together account for nearly half of all dementia cases. Several carry an outsized burden in women. One stands clearly above the rest.
Hearing loss holds the top spot among all 14 Lancet risk factors, with a weighted population attributable fraction of approximately 7.2% — and an unweighted estimate as high as 15.6%. The association is dose-dependent: the greater the hearing impairment, the greater the dementia risk. The likely mechanism is cognitive load — the brain devoting extra resources to process degraded sound, leaving less reserve for memory and executive function — compounded by the social isolation that untreated hearing loss often causes. Effective, low-risk interventions are already available. Hearing aids and prompt treatment are among the highest-yield steps you can take to protect your long-term brain health. Ask us about hearing screening at your next visit.
PAF ~7.2% weighted, ~15.6% unweighted · Lancet 2024More prevalent in women at every age, depression independently raises dementia risk. Women with limited social support are especially vulnerable. We screen for and treat depression as a core part of whole-person care.
Higher prevalence in womenThe cognitive protection from regular exercise is well established — and the effect appears even stronger in women. Postmenopausal women show particularly notable vascular brain benefits from aerobic activity.
Exercise benefits stronger in womenDiabetes raises dementia risk by 60% overall — but women with diabetes face a 19% greater increase than men with the same diagnosis. Blood sugar management is a priority we take seriously for all our members.
19% greater impact vs. men with diabetesMidlife high blood pressure predicts mild cognitive impairment more strongly in women than in men, and its effects may interact with menopausal hormonal changes. Monitoring and management in your 40s and 50s matters.
Stronger predictor of MCI in womenWomen are more likely to experience loneliness in older age, especially after widowhood. Reduced cognitive engagement from social withdrawal is a real and underappreciated dementia risk factor.
Higher rates in older womenNewly added to the 2024 Lancet list, uncorrected vision loss reduces sensory engagement and accelerates cognitive decline. Regular eye exams and corrective lenses are simple, high-value interventions.
Newly identified Lancet risk factorA 2026 review in Stroke identifies ages 40–65 as the critical prevention window for women. This is when Alzheimer’s-related changes begin accumulating silently, and when lifestyle interventions carry the most weight. The 2024 AHA/ASA guidelines now recommend screening for adverse pregnancy outcomes — including preeclampsia and gestational diabetes — as part of vascular dementia prevention.
A Norwegian study estimated that addressing all 14 Lancet risk factors could prevent more than half of dementia cases, with additional preventive potential specific to women. The research is clear: dementia is not simply what happens when women live longer. It is shaped by a complex, intersecting web of biological, hormonal, and lifestyle factors — and many of them are within reach.
“Midlife is no longer just a risk period to be endured — it’s an intervention opportunity to be seized.”
— 2026 Stroke Review on Women’s Dementia PreventionNo rushed visits, no insurance barriers. If you’re in midlife and thinking about your brain health, bring it up at your next appointment. We’ll review your reproductive history, cardiovascular risk factors, hearing, mood, activity level, and family history — and build a personalized plan with you, not for you.
Sources: 2024 Lancet Commission on Dementia Prevention; COSMIC Consortium meta-analysis (29,850 participants); Journal of Clinical Investigation 2026; Stroke 2026; JAMA Internal Medicine (Bartz et al., 2020); 2024 AHA/ASA Guidelines; HUNT4 70+ Norwegian cohort. This content is for informational purposes only and does not constitute medical advice. © 2026 Hometown Health DPC.



.png)
